Specify a stock or a cryptocurrency in the search bar to get a summary
Taiko Pharmaceutical Co Ltd
4574Taiko Pharmaceutical Co.,Ltd. manufactures and sells over-the-counter (OTC) medicines in Japan and internationally. The company provides OTC medicines for the treatment of loose stools, diarrhea, vomiting, food and water poisoning symptoms, and toothache; and quasi-drugs for regulation of intestinal movements, relieves stomach distention, loose stools, and constipation. It also manufactures and sells infection control products. The company also exports its products. Taiko Pharmaceutical Co.,Ltd. was incorporated in 1946 and is headquartered in Osaka, Japan. Address: 1-4-1, Nishi-Honmachi, Osaka, Japan, 550-0005
Analytics
WallStreet Target Price
516 816.3 JPYP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures 4574
Dividend Analytics 4574
Dividend growth over 5 years
–Continuous growth
2 yearsPayout Ratio 5 years average
24 %Dividend History 4574
Stock Valuation 4574
Financials 4574
Results | 2019 | Dynamics |